Southrifty Drug Inc
Pharmaceutical ManufacturingNew York, United States2-10 Employees
Southrifty Drug Inc is a Pharmaceuticals company located in 54 Jagger Ln, Southampton, New York, United States.
Niche Market Focus Southrifty Drug Inc operates as a small-scale pharmaceutical manufacturer with a local presence in Southampton, New York, indicating opportunities to support personalized or specialized drug manufacturing needs within boutique or regional markets.
Growth Potential With revenue estimated between zero and one million dollars, the company shows potential for growth, especially by leveraging technology, expanding product lines, or increasing regional distribution channels.
Digital Infrastructure Utilizing platforms like Adobe GoLive and Apache servers suggests an interest in maintaining a web presence and online engagement, presenting opportunities to enhance digital marketing, website optimization, or e-commerce capabilities.
Industry Consolidation Positioned within a competitive landscape dominated by large pharmacy brands with extensive employee bases and revenue, Southrifty Drug can benefit from specialized supply chain solutions, niche product sourcing, or contract manufacturing partnerships.
Potential Collaborations The company's small size offers agility for strategic alliances or partnerships with larger pharmaceutical or healthcare firms, which could facilitate technology sharing, distribution expansion, or access to broader markets.
Southrifty Drug Inc uses 3 technology products and services including Adobe GoLive, Apache HTTP Server, Apache, and more. Explore Southrifty Drug Inc's tech stack below.
| Southrifty Drug Inc Email Formats | Percentage |
| First@southriftydrug.com | 50% |
| First@southriftydrug.com | 50% |
Pharmaceutical ManufacturingNew York, United States2-10 Employees
Southrifty Drug Inc is a Pharmaceuticals company located in 54 Jagger Ln, Southampton, New York, United States.
Southrifty Drug Inc's revenue is estimated to be in the range of $1M
Southrifty Drug Inc's revenue is estimated to be in the range of $1M